Establishment and stability of the latent HIV-1 DNA reservoir

eLife

Volumn 5, Issue November2016, 2016, Pages

  Brodin, Johanna ^a   Zanini, Fabio ^b,e   Thebo, Lina ^a   Lanz, Christa ^b   Bratt, Göran ^c   Neher, Richard A ^b   Albert, Jan ^a,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MAX PLANCK INSTITUTE FOR DEVELOPMENTAL BIOLOGY   (Germany)

^c STOCKHOLM SÖDER HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; ANTIRETROVIRUS AGENT;

ANTIRETROVIRAL THERAPY; ARTICLE; DNA SEQUENCE; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; VIRUS REPLICATION; CLASSIFICATION; GENETICS; GENOTYPE; HIV INFECTIONS; PHYSIOLOGY; VIROLOGY; VIRUS LATENCY;

ANTI-RETROVIRAL AGENTS; DNA, VIRAL; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; VIRUS LATENCY;

EID: 85009461075     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.18889     Document Type: Article

References (43)

1. Besson GJ, Lalama CM, Bosch RJ, Gandhi RT, Bedison MA, Aga E, Riddler SA, McMahon DK, Hong F, Mellors JW. 2014. HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy. Clinical Infectious Diseases 59:1312–1321. doi: 10.1093/cid/ciu585
2. Bruner KM, Hosmane NN, Siliciano RF. 2015. Towards an HIV-1 cure: measuring the latent reservoir. Trends in Microbiology 23:192–203. doi: 10.1016/j.tim.2015.01.013
3. Bruner KM, Murray AJ, Pollack RA, Soliman MG, Laskey SB, Capoferri AA, Lai J, Strain MC, Lada SM, Hoh R, Ho YC, Richman DD, Deeks SG, Siliciano JD, Siliciano RF. 2016. Defective proviruses rapidly accumulate during acute HIV-1 infection. Nature Medicine 22:1043–1049. doi: 10.1038/nm.4156
4. Buzón MJ, Massanella M, Llibre JM, Esteve A, Dahl V, Puertas MC, Gatell JM, Domingo P, Paredes R, Sharkey M, Palmer S, Stevenson M, Clotet B, Blanco J, Martinez-Picado J. 2010. HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. Nature Medicine 16:460–465. doi: 10.1038/nm.2111
5. Chomont N, DaFonseca S, Vandergeeten C, Ancuta P, Sékaly RP. 2011. Maintenance of CD4+ T-cell memory and HIV persistence: keeping memory, keeping HIV. Current Opinion in HIV and AIDS 6:30–36. doi: 10.1097/COH.0b013e3283413775
6. Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio FA, Yassine-Diab B, Boucher G, Boulassel MR, Ghattas G, Brenchley JM, Schacker TW, Hill BJ, Douek DC, Routy JP, Haddad EK, Sékaly RP. 2009. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nature Medicine 15:893–900. doi: 10.1038/nm.1972
7. Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, Hermankova M, Chadwick K, Margolick J, Quinn TC, Kuo YH, Brookmeyer R, Zeiger MA, Barditch-Crovo P, Siliciano RF. 1997. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387:183–188. doi: 10.1038/387183a0
8. Chun TW, Finzi D, Margolick J, Chadwick K, Schwartz D, Siliciano RF. 1995. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nature Medicine 1:1284–1290. doi: 10.1038/nm1295-1284
9. Cock PJ, Antao T, Chang JT, Chapman BA, Cox CJ, Dalke A, Friedberg I, Hamelryck T, Kauff F, Wilczynski B, de Hoon MJ. 2009. Biopython: freely available Python tools for computational molecular biology and bioinformatics. Bioinformatics 25:1422–1423. doi: 10.1093/bioinformatics/btp163
10. Cohn LB, Silva IT, Oliveira TY, Rosales RA, Parrish EH, Learn GH, Hahn BH, Czartoski JL, McElrath MJ, Lehmann C, Klein F, Caskey M, Walker BD, Siliciano JD, Siliciano RF, Jankovic M, Nussenzweig MC. 2015. HIV-1 integration landscape during latent and active infection. Cell 160:420–432. doi: 10.1016/j.cell.2015.01.020
11. Eriksson S, Graf EH, Dahl V, Strain MC, Yukl SA, Lysenko ES, Bosch RJ, Lai J, Chioma S, Emad F, Abdel-Mohsen M, Hoh R, Hecht F, Hunt P, Somsouk M, Wong J, Johnston R, Siliciano RF, Richman DD, O’Doherty U, et al. 2013. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathogens 9: e1003174. doi: 10.1371/journal.ppat.1003174
12. Evering TH, Mehandru S, Racz P, Tenner-Racz K, Poles MA, Figueroa A, Mohri H, Markowitz M. 2012. Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection. PLoS Pathogens 8:e1002506. doi: 10.1371/journal.ppat.1002506
13. Frenkel LM, Wang Y, Learn GH, McKernan JL, Ellis GM, Mohan KM, Holte SE, De Vange SM, Pawluk DM, Melvin AJ, Lewis PF, Heath LM, Beck IA, Mahalanabis M, Naugler WE, Tobin NH, Mullins JI. 2003. Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy. Journal of Virology 77:5721–5730. doi: 10.1128/JVI.77.10.5721-5730.2003
14. Günthard HF, Frost SD, Leigh-Brown AJ, Ignacio CC, Kee K, Perelson AS, Spina CA, Havlir DV, Hezareh M, Looney DJ, Richman DD, Wong JK. 1999. Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy. Journal of Virology 73:9404–9412
15. Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, Schmidt D, Hoh R, Neese R, Macallan D, Deeks S, McCune JM. 1999. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nature Medicine 5:83–89. doi: 10.1038/4772
16. Ho YC, Shan L, Hosmane NN, Wang J, Laskey SB, Rosenbloom DI, Lai J, Blankson JN, Siliciano JD, Siliciano RF. 2013. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 155:540–551. doi: 10.1016/j.cell.2013.09.020
17. Hunter JD. 2007. Matplotlib: A 2D graphics environment. Computing in Science & Engineering 9:90–95. doi: 10.1109/MCSE.2007.55
18. Imamichi H, Natarajan V, Adelsberger JW, Rehm CA, Lempicki RA, Das B, Hazen A, Imamichi T, Lane HC. 2014. Lifespan of effector memory CD4+ T cells determined by replication-incompetent integrated HIV-1 provirus. AIDS 28:1091–1099. doi: 10.1097/QAD.0000000000000223
19. Jabara CB, Jones CD, Roach J, Anderson JA, Swanstrom R. 2011. Accurate sampling and deep sequencing of the HIV-1 protease gene using a primer ID. PNAS 108:20166–20171. doi: 10.1073/pnas.1110064108
20. Josefsson L, von Stockenstrom S, Faria NR, Sinclair E, Bacchetti P, Killian M, Epling L, Tan A, Ho T, Lemey P, Shao W, Hunt PW, Somsouk M, Wylie W, Douek DC, Loeb L, Custer J, Hoh R, Poole L, Deeks SG, et al. 2013. The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time. PNAS 110:E4987–E4996. doi: 10.1073/pnas.1308313110
21. Kearney MF, Spindler J, Shao W, Yu S, Anderson EM, O’Shea A, Rehm C, Poethke C, Kovacs N, Mellors JW, Coffin JM, Maldarelli F. 2014. Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy. PLoS Pathogens 10:e1004010. doi: 10.1371/journal.ppat.1004010
22. Kieffer TL, Finucane MM, Nettles RE, Quinn TC, Broman KW, Ray SC, Persaud D, Siliciano RF. 2004. Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads. The Journal of Infectious Diseases 189:1452–1465. doi: 10.1086/382488
23. Kieffer TL, Kwon P, Nettles RE, Han Y, Ray SC, Siliciano RF. 2005. G–>A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo. Journal of Virology 79:1975–1980. doi: 10.1128/JVI.79.3.1975-1980.2005
24. Lorenzo-Redondo R, Fryer HR, Bedford T, Kim EY, Archer J, Kosakovsky Pond SL, Chung YS, Penugonda S, Chipman JG, Fletcher CV, Schacker TW, Malim MH, Rambaut A, Haase AT, McLean AR, Wolinsky SM. 2016. Persistent HIV-1 replication maintains the tissue reservoir during therapy. Nature 530:51–56. doi: 10.1038/nature16933
25. Lori F, Jessen H, Lieberman J, Finzi D, Rosenberg E, Tinelli C, Walker B, Siliciano RF, Lisziewicz J. 1999. Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir. The Journal of Infectious Diseases 180:1827–1832. doi: 10.1086/315113
26. Maldarelli F, Wu X, Su L, Simonetti FR, Shao W, Hill S, Spindler J, Ferris AL, Mellors JW, Kearney MF, Coffin JM, Hughes SH. 2014. HIV latency. specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science 345:179–183. doi: 10.1126/science.1254194
27. Massanella M, Richman DD. 2016. Measuring the latent reservoir in vivo. Journal of Clinical Investigation 126: 464–472. doi: 10.1172/JCI80567
28. McCune JM, Hanley MB, Cesar D, Halvorsen R, Hoh R, Schmidt D, Wieder E, Deeks S, Siler S, Neese R, Hellerstein M. 2000. Factors influencing T-cell turnover in HIV-1-seropositive patients. Journal of Clinical Investigation 105:R1–R8. doi: 10.1172/JCI8647
29. Pogorelyy MV, Elhanati Y, Marcou Q, Sycheva A, Komech E, Nazarov V, Britanova O, Chudakov D, Mamedov I, Lebedev Y, Mora T, Walczak AM. 2016. Persisting fetal clonotypes influence the structure and overlap of adult human T cell receptor repertoires. Bio R 14. doi: 10.1101/039297
30. Price MN, Dehal PS, Arkin AP. 2010. FastTree 2–approximately maximum-likelihood trees for large alignments. PLoS One 5:e9490. doi: 10.1371/journal.pone.0009490
31. Razooky BS, Pai A, Aull K, Rouzine IM, Weinberger LS. 2015. A hardwired HIV latency program. Cell 160:990–1001. doi: 10.1016/j.cell.2015.02.009
32. Ribeiro RM, Mohri H, Ho DD, Perelson AS. 2002. In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted? PNAS 99:15572–15577. doi: 10.1073/pnas.242358099
33. Robins H. 2013. Immunosequencing: applications of immune repertoire deep sequencing. Current Opinion in Immunology 25:646–652. doi: 10.1016/j.coi.2013.09.017
34. Rouzine IM, Weinberger AD, Weinberger LS. 2015. An evolutionary role for HIV latency in enhancing viral transmission. Cell 160:1002–1012. doi: 10.1016/j.cell.2015.02.017
35. Sanchez G, Xu X, Chermann JC, Hirsch I. 1997. Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals. Journal of Virology 71:2233–2240
36. Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, Kovacs C, Gange SJ, Siliciano RF. 2003. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nature Medicine 9:727–728. doi: 10.1038/nm880
37. Stopak K, de Noronha C, Yonemoto W, Greene WC. 2003. HIV-1 vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Molecular Cell 12:591–601. doi: 10.1016/S1097-2765(03)00353-8
38. Strain MC, Little SJ, Daar ES, Havlir DV, Gunthard HF, Lam RY, Daly OA, Nguyen J, Ignacio CC, Spina CA, Richman DD, Wong JK. 2005. Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. The Journal of Infectious Diseases 191:1410–1418. doi: 10.1086/428777809898
39. van der Walt Stefan, Colbert SC, Varoquaux Gaėl. 2011. The NumPy array: A structure for efficient numerical computation. Computing in Science & Engineering 13:22–30. doi: 10.1109/MCSE.2011.37
40. von Stockenstrom S, Odevall L, Lee E, Sinclair E, Bacchetti P, Killian M, Epling L, Shao W, Hoh R, Ho T, Faria NR, Lemey P, Albert J, Hunt P, Loeb L, Pilcher C, Poole L, Hatano H, Somsouk M, Douek D, et al. 2015. Longitudinal genetic characterization reveals that cell proliferation maintains a persistent HIV type 1 DNA pool during effective HIV therapy. Journal of Infectious Diseases 212:596–607. doi: 10.1093/infdis/jiv092
41. Yu Q, König R, Pillai S, Chiles K, Kearney M, Palmer S, Richman D, Coffin JM, Landau NR. 2004. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome. Nature Structural & Molecular Biology 11:435–442. doi: 10.1038/nsmb758
42. Yukl SA, Shergill AK, McQuaid K, Gianella S, Lampiris H, Hare CB, Pandori M, Sinclair E, Günthard HF, Fischer M, Wong JK, Havlir DV. 2010. Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy. AIDS 24:2451–2460. doi: 10.1097/QAD.0b013e32833ef7bb
43. Zanini F, Brodin J, Thebo L, Lanz C, Bratt G, Albert J, Neher RA. 2015. Population genomics of intrapatient HIV-1 evolution. eLife 4:e11282. doi: 10.7554/eLife.11282